The Medicare Payment Advisory Commission (MedPAC) convened a session to discuss the Commission’s findings from its ongoing analysis of Part D data on drug rebates and discounts. Pursuant to the Consolidated Appropriation Act (CAA) of 2021, MedPAC was granted access to direct and indirect remuneration (DIR) fee data reported to the Centers for Medicare and Medicaid Services (CMS). Additionally, the… (Colocho, April 14, 2023) #Cost-Sharing, #Drug Pricing, #Generic Drugs, #Medicare Part D